Sponsor Pipeline

Eddingpharm (Zhuhai) Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
1
Recruiting
1
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-07-31 NCT07738341 GB268 Monotherapy or Combination Therapy for Locally Advanced/Metastatic Breast Cancer… Phase 1/2 Not Yet Recruiting
Active Trials by Phase
Phase 2
1
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07489209 A Dose-exploration Study of EDP167 in HoFH Homozygous Familial Hypercholesterolemia (HoFH) Recruiting
Phase 1/2
NCT07738341 GB268 Monotherapy or Combination Therapy for Locally Advanced/Metastatic Breast Cancer… Breast Cancer (Locally Advanced or Metastatic) Not Yet Recruiting
Disease Areas
Breast Cancer (1)
Get alerts when Eddingpharm (Zhuhai) Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free